Lysyl Oxidase-Like 2 as a Predictor of Hepatocellular Carcinoma in Patients with Hepatitis C Virus after Sustained Virological Response

The authors validated the utility of serum LOXL2 levels as a predictive biomarker for the development of HCC in patients with hepatitis C virus infection who achieved a sustained virological response.